Matchmaking mission in Japan for EU Cluster managers and their SMEs members

Japan is one of the most developed countries in the biotechnology sector, as evidenced by its high number of patents produced is one of the evidences. Although for a long time considered as a closed market, the Japanese health sector is rapidly expanding and increasingly opening its doors to foreign firms. The phenomenon of a rapidly aging population and the recent deregulation in operation creates a favourable environment for foreign companies’ entry in the Japanese health and care market.

свернуть